Literature DB >> 6495149

Initiation of complement activation.

P J Lachmann, N C Hughes-Jones.   

Abstract

The complement system is an excellent one to look at as an example of a triggered enzyme system. It is found to use almost all the strategies of enzyme cascades and for initiation which were discussed in the introduction. The classical pathway is a fine example of an active zymogen form of activation and the alternative pathway is the canonical example of a tickover. Both may also be activated by exogenous enzymes from other systems. The strategies of enzymes waiting for substrates, of substrates waiting for enzymes, and of both waiting for modifying proteins are all seen in various stages of the reaction. There is an association of a linear cascade with the positive feedback amplification loop. This degree of evolutionary adaptation is not only aesthetically pleasing but must be taken to mean that the system is of considerable biological importance and has been over a long evolutionary time span.

Mesh:

Substances:

Year:  1984        PMID: 6495149     DOI: 10.1007/bf01893018

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  47 in total

1.  Chemical analysis and electron microscopy studies of human C1q prepared by different methods.

Authors:  H R Knobel; W Villiger; H Isliker
Journal:  Eur J Immunol       Date:  1975-01       Impact factor: 5.532

2.  A. The blood clotting mechanism. The development of a theory of blood coagulation.

Authors:  R G Macfarlane
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-07-01

3.  Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.

Authors:  M D Kazatchkine; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

Review 4.  Antibody-independent activation of C1, the first component of complement.

Authors:  M Loos
Journal:  Ann Immunol (Paris)       Date:  1982 Mar-Apr

Review 5.  [Biochemical data on C1 intrinsic activation (author's transl)].

Authors:  M G Colomb; J C Bensa; C L Villiers; G J Arlaud
Journal:  Ann Immunol (Paris)       Date:  1982 Mar-Apr

6.  The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies.

Authors:  N C Hughes-Jones; B D Gorick; J C Howard
Journal:  Eur J Immunol       Date:  1983-08       Impact factor: 5.532

7.  A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement.

Authors:  R J Ziccardi
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

8.  Antigen-independent activation of the first component of complement C1 by chemically crosslinked rabbit IgG-oligomers.

Authors:  J Tschopp; T Schulthess; J Engel; J C Jaton
Journal:  FEBS Lett       Date:  1980-04-07       Impact factor: 4.124

9.  Rabbit blood coagulation factor XI. Purification and properties.

Authors:  R C Wiggins; C G Cochrane; J H Griffin
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

10.  Formation of complement subcomponent C1q-immunoglobulin G complex. Thermodynamic and chemical-modification studies.

Authors:  E J Emanuel; A D Brampton; D R Burton; R A Dwek
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

View more
  38 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Use of time-resolved FRET to validate crystal structure of complement regulatory complex between C3b and factor H (N terminus).

Authors:  Isabell C Pechtl; Robert K Neely; David T F Dryden; Anita C Jones; Paul N Barlow
Journal:  Protein Sci       Date:  2011-12       Impact factor: 6.725

3.  The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.

Authors:  Y M Lucisano Valim; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

4.  Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis.

Authors:  Nirmal K Banda; Minoru Takahashi; Brandt Levitt; Magdalena Glogowska; Jessica Nicholas; Kazue Takahashi; Gregory L Stahl; Teizo Fujita; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2010-09-24       Impact factor: 5.422

5.  Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.

Authors:  Tamara Montes; Agustín Tortajada; B Paul Morgan; Santiago Rodríguez de Córdoba; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

6.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.

Authors:  Meike Heurich; Ruben Martínez-Barricarte; Nigel J Francis; Dawn L Roberts; Santiago Rodríguez de Córdoba; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 7.  The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.

Authors:  Joshua M Thurman; Ashley Frazer-Abel; V Michael Holers
Journal:  Arthritis Rheumatol       Date:  2017-10-17       Impact factor: 10.995

8.  Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.

Authors:  O F Ramos; G Sármay; E Klein; E Yefenof; J Gergely
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.

Authors:  Sarah E Sartain; Nancy A Turner; Joel L Moake
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

10.  Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.

Authors:  G Doekes; J Schouten; A Cats; M R Daha
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.